Human VEGF165 Antibody

Catalog # Availability Size / Price Qty
AF-293-NA
AF-293-SP
Best Seller
Detection of Human VEGF by Western Blot.
8 Images
Product Details
Citations (86)
FAQs
Supplemental Products
Reviews (2)

Human VEGF165 Antibody Summary

Species Reactivity
Human
Specificity
Detects human VEGF in direct ELISAs and Western blots.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human VEGF165
Ala27-Arg191
Accession # NP_001165097.1
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details.
*Small pack size (-SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
5-10 µg/mL
See below
Immunohistochemistry
3-15 µg/mL
See below
Dual RNAscope ISH-IHC
5-15 µg/mL
Immersion fixed paraffin-embedded sections of human liver
Immunocytochemistry
5-15 µg/mL
See below
Neutralization
Measured by its ability to neutralize VEGF165-induced proliferation in HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci. USA 87:1323. The Neutralization Dose (ND50) is typically 0.02‑0.12 µg/mL in the presence of 10 ng/mL Recombinant Human VEGF165.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Western Blot Detection of Human VEGF antibody by Western Blot. View Larger

Detection of Human VEGF by Western Blot. Western blot shows lysates of human lung tissue, human kidney tissue, and human liver tissue. PVDF membrane was probed with 5-10 µg/mL of Goat Anti-Human VEGF 165Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-293-NA) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (HAF017). A specific band was detected for VEGF at approximately 27 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Immunocytochemistry VEGF antibody in HUVEC Cells by Immunocytochemistry (ICC). View Larger

VEGF in HUVEC Cells. VEGF was detected in immersion fixed human umbilical vein endothelial cells (HUVECs) using Goat Anti-Human VEGF165 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-293-NA) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (yellow; NL001) and counter-stained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Non-adherent Cells.

Immunohistochemistry VEGF antibody in Human Liver Cancer Tissue by Immunohistochemistry (IHC-P). View Larger

VEGF in Human Liver Cancer Tissue. VEGF was detected in immersion fixed paraffin-embedded sections of human liver cancer tissue using Goat Anti-Human VEGF165 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-293-NA) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Goat IgG VisUCyte™ HRP Polymer Antibody (VC004). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cytoplasm in cancer cells. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.

Neutralization Cell Proliferation Induced by VEGF<SUB>165</SUB>and Neutralization by Human VEGF Antibody. View Larger

Cell Proliferation Induced by VEGF165and Neutralization by Human VEGF Antibody. Recombinant Human VEGF165 (293-VE) stimulates proliferation in HUVEC human umbilical vein endothelial cells in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human VEGF165 (10 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human VEGF165 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-293-NA). The ND50 is typically 0.02‑0.12 µg/mL.

Western Blot Detection of Human VEGF by Western Blot View Larger

Detection of Human VEGF by Western Blot VEGF expression determined by Western blot and immunoprecipitation.A. Western blot using LiCor Odyssey to simultaneously image pan-VEGF and VEGF-A165b probed western blot. Two different podocyte samples, and a primary RPE sample were run on a gel and probed with antibodies to VEGF-A165b (mouse monoclonal anti-CTRSLTRKD, and 680nm-donkey anti-mouse, top image) and pan-VEGF (rabbit polyclonal anti-VEGF, and 800nm-donkey anti-rabbit, middle image). The bottom image is the pseudocoloured combined image (600nm green, 800nm red). Note the red VEGF165, but yellow VEGF-A165b. MWM = molecular weight marker. d = dimer, m = monomer. B. Protein extracted from human cell lines (adenoma and adenocarcinoma(AC)) subjected to immunoprecipitation (IP) for VEGF-A165b and immunoblotting (IB) for total VEGF-A. A clear strong band was seen in the IP for both cell types at ∼23kDa and ∼46kDa, consistent with the IP for recombinant human VEGF-A165b. A weaker band was seen in the input protein (not subjected to IP), and a second band slightly higher in the AC. A weak band at approximately 56kDa and 28kDa was seen in all lanes subjected to IP, including the VEGF-A165a band, but not seen in the recombinant human VEGF-A165b not subjected to IP, indicating that this is cross reactivity with the IgG. This band was clearly above the VEGF-A165b bands. C. Protein extracted from human cell lines (adenoma and adenocarcinoma(AC)) subjected to immunoprecipitation (IP) for VEGF-A and immunoblotting (IB) for VEGF-A165b. A clear strong band was seen in the IP for both cell types at ∼23kDa, the same size as recombinant human VEGF-A165b. In the input a band at ∼46Da was seen predominantly, for both cell types, labelled as VEGF-A165b dimers. D. Mouse tissues probed with VEGF-A165b antibody detect mouse IgG due to the secondary antibody. Top image, western blot of mouse tissues, recombinant mouse IgG or human VEGF-A165b or VEGF-A165b probed with mouse anti-CTRSLTRKD, and 680nm-donkey anti-mouse IgG. Bottom image blot of same tissues, probed without primary antibody. The same bands are seen in the mouse tissues. Spl = spleen, Col = colon, Hrt = heart, Lng = lung, Liv = liver, Kid = kidney. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/23935865), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human VEGF by Western Blot View Larger

Detection of Human VEGF by Western Blot Inhibitor of differentiation 4 (ID4) expression in breast cancer cells leads to the activation of an angiogenic programme in macrophages. a Expression matrix representing a panel of angiogenic factors evaluated using TaqMan Low-Density Arrays (TLDA) in macrophages obtained by 1,25-dihydroxyvitamin D3 (VitD3)-mediated differentiation of HL60 cells and subsequently cultured in RPMI medium or in conditioned media (CM) from control (EV) or ID4-overexpressing (ID4) MDA-MB-468 breast cancer cells. b Western blot showing ID4-HA overexpression in MDA-MB-468 cells. c Selected genes modulated in the arrays were evaluated by RT-qPCR in macrophages obtained from VitD3-mediated differentiation of U937 cells and subsequently cultivated in RPMI medium (CTR) or in CM from control (CM si-SCR) or ID4-depleted (CM si-ID4) MDA-MB-468 cells. d Western blot analysis showing the level of ID4 protein after transfection of the indicated small interfering RNAs (siRNAs) in MDA-MB-468 cells. e–g Western blot analysis of ephrin B2 (EphB2), granulin (GRN) and hypoxia-inducible factor (HIF)-1A proteins in differentiated U937 cells cultured in CM si-SCR or CM si-ID4 from MDA-MB-468 cells. h Immunofluorescence analysis of HIF-1A protein performed in differentiated U937 cells cultured in the presence of CM si-SCR or CM si-ID4 from MDA-MB-468 cells. i Western blotting showing the efficiency of vascular endothelial growth factor A (VEGFA) depletion by siRNA transfection in MDA-MB-468 cells used to prepare CM used in experiments shown in (j). j RT-qPCR analysis of the indicated messenger RNAs in U937 macrophages cultivated in the presence of CM from control (si-SCR) or VEGFA-depleted (si-VEGFA) MDA-MB-468 cells. k RT-qPCR analysis of the indicated genes in differentiated U937 cells cultivated in RPMI medium or in CM from MDA-MB-468 cells in the presence of VEGFA blocking antibody (Ab) or a control Ab. Specifically, VEGFA blocking Ab or control Ab were incubated with CM for 30 minutes at room temperature and CM plus Ab was subsequently used to culture U937 cells for 48 hours. Results from at least three biological replicates are shown. Data are presented as mean ± SEM. *P < 0.05, **P < 0.005, ***P < 0.0005 calculated by two-tailed t test. Image collected and cropped by CiteAb from the following open publication (https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-0990-2), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human VEGF by Western Blot View Larger

Detection of Human VEGF by Western Blot Western blot analysis of the effects of RNA interference on VEGF expression in HTF cells. (a) Relative expression of VEGF in cells treated with shRNA-2 and shRNA-3; (b) protein expression levels in treated groups and naïve HTF controls. ∗∗∗p < 0.01. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/28168047), licensed under a CC-BY license. Not internally tested by R&D Systems.

In-situ Hybridization View Larger

Detection of VEGF in Human Liver. Formalin-fixed paraffin-embedded tissue sections of human liver were probed for VEGF mRNA (ACD RNAScope Probe, catalog #423168, Fast Red chromogen, ACD catalog # 322750). Adjacent tissue section was processed for immunohistochemistry using goat anti-human VEGF polyclonal antibody (R&D Systems catalog # AF-293-NA) at 5ug/mL with overnight incubation at 4 degrees Celsius followed by incubation with anti-goat IgG VisUCyte HRP Polymer Antibody (Catalog # VC004) and DAB chromogen (yellow-brown). Tissue was counterstained with hematoxylin (blue). Specific staining was localized to hepatocytes.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: VEGF

Vascular Endothelial Growth Factor (VEGF or VEGF-A), also known as Vascular Permeability Factor (VPF), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the PDGF family that is characterized by the presence of eight conserved cysteine residues and a cystine knot structure. VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189. Human VEGF165 is an approximately 44 kDa molecular weight homodimer sharing 88% aa sequence identity with corresponding regions of mouse and rat, 96% with porcine, 95% with canine, and 93% with feline, equine and bovine VEGF, respectively. VEGF binds the type I transmembrane receptor tyrosine kinases VEGF R1 (also called Flt-1) and VEGF R2 (Flk-1/KDR) on endothelial cells. Although VEGF affinity is highest for binding to VEGF R1, VEGF R2 appears to be the primary mediator of VEGF angiogenic activity. VEGF165 binds the Semaphorin receptor, Neuropilin-1 and promotes complex formation with VEGF R2. VEGF is required during embryogenesis and functions to regulate the proliferation, migration, and survival of endothelial cells. In adults, VEGF functions mainly in wound healing and the female reproductive cycle. Pathologically, it is involved in tumor angiogenesis and vascular leakage. Circulating VEGF levels correlate with disease activity in autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus. VEGF is induced by hypoxia and cytokines such as IL-1, IL-6, IL-8, Oncostatin M (OSM) and TNF-alpha.

Long Name
Vascular Endothelial Growth Factor
Entrez Gene IDs
7422 (Human); 22339 (Mouse); 83785 (Rat); 281572 (Bovine); 403802 (Canine); 493845 (Feline); 30682 (Zebrafish)
Alternate Names
MVCD1; VAS; vascular endothelial growth factor A; Vascular permeability factor; Vasculotropin; VEGF; VEGFA; VEGF-A; VEGFMGC70609; VPF; VPFvascular endothelial growth factor

Product Datasheets

You must select a language.

x

Citations for Human VEGF165 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

86 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Reduced NGF in Gastric Endothelial Cells Is One of the Main Causes of Impaired Angiogenesis in Aging Gastric Mucosa
    Authors: A Ahluwalia, MK Jones, N Hoa, E Zhu, T Brzozowski, AS Tarnawski
    Cell Mol Gastroenterol Hepatol, 2018-05-17;6(2):199-213.
  2. Angiogenic Potential of Tissue Engineered Cartilage From Human Mesenchymal Stem Cells Is Modulated by Indian Hedgehog and Serpin E1
    Authors: Yannick Nossin, Eric Farrell, Wendy J. L. M. Koevoet, Rodrigo A. Somoza, Arnold I. Caplan, Bent Brachvogel et al.
    Frontiers in Bioengineering and Biotechnology
  3. An ultrathin membrane mediates tissue-specific morphogenesis and barrier function in a human kidney chip
    Authors: Mou, X;Shah, J;Roye, Y;Du, C;Musah, S;
    Science advances
    Species: Human
    Sample Types: Whole Cells
    Applications: Immunocytochemistry
  4. Pigment epithelium?derived factor inhibits proliferation, invasion and angiogenesis, and induces ferroptosis of extravillous trophoblasts by targeting Wnt???catenin/VEGF signaling  in placenta accreta spectrum
    Authors: Li, R;Weng, X;Hu, X;Wang, J;Zheng, L;
    Molecular medicine reports
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  5. The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF165 and downregulating VEGF165b
    Authors: Quan, B;Li, Z;Yang, H;Li, S;Yan, X;Wang, Y;
    Heliyon
    Species: Human
    Sample Types: Tissue Homogenates
    Applications: Western Blot
  6. Amperometric Biosensor for Quantitative Measurement Using Sandwich Immunoassays
    Authors: Pedersen, T;Fojan, P;Pedersen, AKN;Magnusson, NE;Gurevich, L;
    Biosensors
    Species: Human
    Sample Types: Recombinant Protein
    Applications: ELISA Capture
  7. Inhibition of triple negative breast cancer-associated inflammation and progression by N- acylethanolamine acid amide hydrolase (NAAA)
    Authors: O Benchama, MS Malamas, K Praveen, EC Ethier, MK Williams, A Makriyanni, HK Avraham
    Scientific Reports, 2022-12-23;12(1):22255.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  8. Macrophage NFATC2 mediates angiogenic signaling during mycobacterial infection
    Authors: WJ Brewer, AM Xet-Mull, A Yu, MI Sweeney, EM Walton, DM Tobin
    Cell Reports, 2022-12-13;41(11):111817.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  9. Retinal Pigment Epithelium-Secreted VEGF-A Induces Alpha-2-Macroglobulin Expression in Endothelial Cells
    Authors: GL Lehmann, M Ginsberg, DJ Nolan, C Rodríguez, J Martínez-G, S Zeng, AP Voigt, RF Mullins, S Rafii, E Rodriguez-, I Benedicto
    Cells, 2022-09-24;11(19):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  10. Preferential stimulation of melanocytes by M2 macrophages to produce melanin through vascular endothelial growth factor
    Authors: H Han, Y Kim, H Mo, SH Choi, K Lee, YA Rim, JH Ju
    Scientific Reports, 2022-04-19;12(1):6416.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  11. Extracellular vesicle-encapsulated microRNA-424 exerts inhibitory function in ovarian cancer by targeting MYB
    Authors: P Li, H Xin, L Lu
    Journal of Translational Medicine, 2021-01-06;19(1):4.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  12. Role of IL-36 Cytokines in the Regulation of Angiogenesis Potential of Trophoblast Cells
    Authors: JM Murrieta-C, RN Gutiérrez-, HM El-Shorafa, T Groten, S Rodríguez-, ME Cancino-Di, JC Cancino-Di, RR Favaro, UR Markert, DM Morales-Pr
    International Journal of Molecular Sciences, 2020-12-30;22(1):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  13. Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF?1&alpha and VEGF expression
    Authors: D Dong, Y Fu, F Chen, J Zhang, H Jia, J Li, H Wang, J Wen
    Mol Med Rep, 2020-11-20;23(1):.
    Species: Human
    Sample Types: Cell Lysates, Whole Cells
    Applications: Neutralization, Western Blot
  14. Multiple Sclerosis Treatment and Melanoma Development
    Authors: ML Carbone, PM Lacal, S Messinese, L De Giglio, C Pozzilli, S Persechino, C Mazzanti, CM Failla, G Pagnanelli
    Int J Mol Sci, 2020-04-22;21(8):.
    Species: Human
    Sample Types: Whole Cells
    Applications: ELISA
  15. Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages
    Authors: S Donzelli, A Sacconi, C Turco, E Gallo, E Milano, I Iosue, G Blandino, F Fazi, G Fontemaggi
    Cells, 2020-02-11;9(2):.
    Species: Human
    Sample Types: Cell Culture Lysates
    Applications: Western Blot
  16. Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
    Authors: F Njau, N Shushakova, H Schenk, VC Wulfmeyer, R Bollin, J Menne, H Haller
    PLoS ONE, 2020-01-14;15(1):e0218494.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  17. Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy
    Authors: JH Wu, YN Li, AQ Chen, CD Hong, CL Zhang, HL Wang, YF Zhou, PC Li, Y Wang, L Mao, YP Xia, QW He, HJ Jin, ZY Yue, B Hu
    EMBO Mol Med, 2020-01-13;12(2):e10154.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: Neutralization
  18. Activated androgen receptor accelerates angiogenesis in cutaneous neurofibroma by regulating VEGFA transcription
    Authors: Jing Jia, Haibao Zhang, Hongke Zhang, Huicong Du, Wenbo Liu, Maoguo Shu
    International Journal of Oncology
  19. Impact of heat therapy on recovery after eccentric exercise in humans
    Authors: Kyoungrae Kim, Shihuan Kuang, Qifan Song, Timothy P. Gavin, Bruno T. Roseguini
    Journal of Applied Physiology
  20. Qingre Baidu mixture‑induced effect of AI‑2 on Staphylococcus�aureus and Pseudomonas�aeruginosa biofilms in chronic and refractory wounds
    Authors: Wei Shan, Yunfei Wang, Zhen Zhang, Jie Xing, Jienan Xu, Wen Xiao et al.
    Experimental and Therapeutic Medicine
  21. Rapid Production of Human VEGF-A following Intradermal Injection of Modified VEGF-A mRNA Demonstrated by Cutaneous Microdialysis in the Rabbit and Pig In Vivo
    Authors: S Pehrsson, M Hölttä, G Linhardt, RF Danielson, L Carlsson
    Biomed Res Int, 2019-01-15;2019(0):3915851.
    Species: Transgenic Rabbit
    Sample Types: Microdialysates
    Applications: Column
  22. Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages
    Authors: S Donzelli, E Milano, M Pruszko, A Sacconi, S Masciarell, I Iosue, E Melucci, E Gallo, I Terrenato, M Mottolese, M Zylicz, A Zylicz, F Fazi, G Blandino, G Fontemaggi
    Breast Cancer Res., 2018-06-19;20(1):59.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  23. Streamlined circular proximity ligation assay provides high stringency and compatibility with low-affinity antibodies
    Authors: R Jalili, J Horecka, JR Swartz, RW Davis, HHJ Persson
    Proc. Natl. Acad. Sci. U.S.A., 2018-01-16;0(0):.
    Applications: Affinity Assay
  24. Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease
    Authors: J Ikari, AJ Nelson, J Obaid, A Giron-Mart, K Ikari, F Makino, S Iwasawa, Y Gunji, M Farid, X Wang, H Basma, D Demeo, C Feghali-Bo, O Holz, K Rabe, X Liu, SI Rennard
    PLoS ONE, 2017-09-07;12(9):e0184039.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: ELISA Development (Capture)
  25. A randomized, single-blind, Phase I trial (INVICTAN-1) assessing the bioequivalence and safety of BI 695502, a bevacizumab biosimilar candidate, in healthy subjects
    Authors: W Hettema, C Wynne, B Lang, M Altendorfe, N Czeloth, R Lohmann, S Athalye, D Schliephak
    Expert Opin Investig Drugs, 2017-07-12;0(0):.
    Species: Human
    Sample Types: Protein
    Applications: ELISA Development (Detection)
  26. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression
    Authors: WW Xu, B Li, XY Guan, SK Chung, Y Wang, YL Yip, SY Law, KT Chan, NP Lee, KW Chan, LY Xu, EM Li, SW Tsao, QY He, AL Cheung
    Nat Commun, 2017-02-10;8(0):14399.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  27. Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
    Authors: Matthew T Cook, Yayun Liang, Cynthia Besch-Williford, Salman M Hyder
    Breast Cancer: Targets and Therapy
  28. Suppression of Human Tenon Fibroblast Cell Proliferation by Lentivirus-Mediated VEGF Small Hairpin RNA
    Authors: Zhongqiu Li, Wen Hua, Xuedong Li, Wei Wang
    Journal of Ophthalmology
  29. CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells
    Authors: S Yang, F Qi, C Tang, H Wang, H Qin, X Li, J Li, W Wang, C Zhao, H Gao
    Oncol Lett, 2016-12-14;13(2):898-904.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  30. PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently
    Authors: L Zheng, C Zhao, Y Du, X Lin, Y Jiang, C Lee, G Tian, J Mi, X Li, Q Chen, Z Ye, L Huang, S Wang, X Ren, L Xing, W Chen, D Huang, Z Gao, S Zhang, W Lu, Z Tang, B Wang, R Ju, X Li
    Oncotarget, 2016-11-22;7(47):77902-77915.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  31. Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors
    Authors: Jussara S. Michaloski, Alexandre R. Redondo, Leila S. Magalhães, Caio C. Cambui, Ricardo J. Giordano
    Science Advances
  32. Clinicopathological implications of vascular endothelial growth factor 165b expression in oral squamous cell carcinoma stroma
    Authors: MASAHIRO NAGASAKI, SEIJI KONDO, YOSHIKI MUKUDAI, TAKAAKI KAMATANI, AYAKO AKIZUKI, ATSUSHI YASO et al.
    Oncology Reports
  33. Efficacy of Antibody Delivery to the Retina and Optic Nerve by Topical Administration
    Authors: Stacy Hu, Steven Koevary
    Journal of Ocular Pharmacology and Therapeutics
  34. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1 alpha -dependent and -independent manners
    Authors: Yanan Zhang, Jie Liu, Shibin Wang, Xiaoli Luo, Yang Li, Zhaohui Lv et al.
    Oncotarget
  35. The Cytoprotective Effects of Human Endothelial Progenitor Cell-Conditioned Medium against an Ischemic Insult Are Not Dependent on VEGF and IL-8
    Authors: Stefano Di Santo, Anna-Lena Fuchs, Ramesh Periasamy, Stefanie Seiler, Hans Rudolf Widmer
    Cell Transplantation
  36. Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism
    Authors: Taylor W. Harvey, Jason E. Engel, Alejandro R. Chade
    American Journal of Nephrology
  37. The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer
    Authors: Yanan Zhang, Jie Liu, Jing Lin, Lei Zhou, Yuhua Song, Bo Wei et al.
    Oncotarget
  38. Differential Protein Expression Profiles in Glaucomatous Trabecular Meshwork: An Evaluation Study on a Small Primary Open Angle Glaucoma Population
    Authors: Alessandra Micera, Luciano Quaranta, Graziana Esposito, Irene Floriani, Augusto Pocobelli, Sergio Claudio Saccà et al.
    Advances in Therapy
  39. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.
    Authors: Gao Y, Zhou Z, Lu S, Huang X, Zhang C, Jiang R, Yao A, Sun B, Wang X
    Stem Cells, 2016-01-13;34(4):1112-22.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  40. Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6
    Authors: Yvonne Volz, David Koschut, Alexandra Matzke-Ogi, Marina S. Dietz, Christos Karathanasis, Ludovic Richert et al.
    Bioscience Reports
  41. Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling.
    Authors: Shvartsman, Dmitry, Storrie-White, Hannah, Lee, Kangwon, Kearney, Cathal, Brudno, Yevgeny, Ho, Nhi, Cezar, Christin, McCann, Corey, Anderson, Erin, Koullias, John, Tapia, Juan Car, Vandenburgh, Herman, Lichtman, Jeff W, Mooney, David J
    Mol Ther, 2014-04-28;22(7):1243-53.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  42. MMP9 processing of HSPB1 regulates tumor progression.
    Authors: Choi, Seo-hyun, Lee, Hae-June, Jin, Yeung Ba, Jang, Junho, Kang, Ga-young, Lee, Minyoung, Kim, Chun-Ho, Kim, Joon, Yoon, Sam S, Lee, Yun-sil, Lee, Yoon-Jin
    PLoS ONE, 2014-01-20;9(1):e85509.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: Western Blot
  43. Simple patterned nanofiber scaffolds and its enhanced performance in immunoassay.
    Authors: Wang, Jing, Kang, Qin-shu, Lv, Xiao-gua, Song, Jia, Zhan, Na, Dong, Wei-guo, Huang, Wei-hua
    PLoS ONE, 2013-12-10;8(12):e82888.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Immunoassay Development
  44. High-Content Analysis to Leverage a Robust Phenotypic Profiling Approach to Vascular Modulation
    Authors: Beverley J. Isherwood, Rebecca E. Walls, Mark E. Roberts, Thomas M. Houslay, Sandra R. Brave, Simon T. Barry et al.
    J Biomol Screen
  45. Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype.
    Authors: Orecchia A, Mettouchi A, Uva P, Simon G, Arcelli D, Avitabile S, Ragone G, Meneguzzi G, Pfenninger K, Zambruno G, Failla C
    FASEB J, 2013-10-30;28(2):692-704.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  46. Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness.
    Authors: Ruffini F, Tentori L, Dorio A, Arcelli D, D'Amati G, D'Atri S, Graziani G, Lacal P
    Oncol Rep, 2013-10-10;30(6):2887-96.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: ELISA Development
  47. Detection of VEGF-A(xxx)b isoforms in human tissues.
    Authors: Bates, David O, Mavrou, Athina, Qiu, Yan, Carter, James G, Hamdollah-Zadeh, Maryam, Barratt, Shaney, Gammons, Melissa, Millar, Ann B, Salmon, Andrew H, Oltean, Sebastia, Harper, Steven J
    PLoS ONE, 2013-07-31;8(7):e68399.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation, Western Blot
  48. Platelet-Rich Plasma Promotes the Proliferation of Human Muscle Derived Progenitor Cells and Maintains Their Stemness
    Authors: Hongshuai Li, Arvydas Usas, Minakshi Poddar, Chien-Wen Chen, Seth Thompson, Bahar Ahani et al.
    PLoS ONE
  49. Neuroblastoma-derived TGF-beta1 modulates the chemokine receptor repertoire of human resting NK cells.
    Authors: Castriconi R, Dondero A, Bellora F, Moretta L, Castellano A, Locatelli F, Corrias M, Moretta A, Bottino C
    J Immunol, 2013-04-10;190(10):5321-8.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  50. Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal Adenocarcinoma
    Authors: M. J. D. Prins, R. J. J. Verhage, F. J. W. ten Kate, R. van Hillegersberg
    Journal of Gastrointestinal Surgery
  51. Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertility
    Authors: Y Qiu, M Seager, A Osman, J Castle-Miller, H Bevan, D J Tortonese et al.
    REPRODUCTION
  52. Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis.
    Authors: Zhao X, Qureshi F, Eastman PS, Manning WC, Alexander C, Robinson WH, Hesterberg LK
    J. Immunol. Methods, 2012-02-17;378(1):72-80.
    Species: Human
    Sample Types: Serum
    Applications: ELISA Development
  53. Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study
    Authors: Michael Lichtenauer, Michael Mildner, Konrad Hoetzenecker, Matthias Zimmermann, Bruno Karl Podesser, Wolfgang Sipos et al.
    Basic Research in Cardiology
  54. Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression
    Authors: F. Ruffini, C.M. Failla, A. Orecchia, M.R. Bani, A.S. Dorio, C. Fortes et al.
    British Journal of Dermatology
  55. Canine Bone Marrow Derived Mesenchymal Stromal Cells Suppress Allo-Reactive Lymphocyte Proliferation in Vitro but Fail to Enhance Engraftment in Canine Bone Marrow Transplantation
    Authors: Won Sik Lee, Yasuhiro Suzuki, Scott S. Graves, Mineo Iwata, G.M. Venkataraman, Marco Mielcarek et al.
    Biology of Blood and Marrow Transplantation
  56. Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration.
    Authors: Fan F, Samuel S, Gaur P
    Br. J. Cancer, 2011-03-15;104(8):1270-7.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  57. Isolation and Properties of an In Vitro Human Outer Blood-Retinal Barrier Model
    Authors: Robin D. Hamilton, Lopa Leach
    Methods in Molecular Biology
  58. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Authors: Brave SR, Eberlein C, Shibuya M, Wedge SR, Barry ST
    Angiogenesis, 2010-10-16;13(4):337-47.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  59. Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability
    Authors: Yan Qiu, Joanne Ferguson, Sebastian Oltean, Chris R. Neal, Amit Kaura, Heather Bevan et al.
    Journal of the American Society of Nephrology
  60. VEGF in the lung: a role for novel isoforms.
    Authors: Varet J, Varet, Julia, Douglas SK, Douglas, Samantha, Gilmartin L, Gilmartin, Laura, Medford, Andrew R, Bates, David O, Harper, Steven J, Millar, Ann B
    Am J Physiol Lung Cell Mol Physiol, 2010-03-12;298(6):L768-74.
    Species: Human
    Sample Types: BALF
    Applications: ELISA Development
  61. Anchoring of Vascular Endothelial Growth Factor to Surface-Immobilized Heparin on Pancreatic Islets: Implications for Stimulating Islet Angiogenesis
    Authors: Sanja Cabric, Javier Sanchez, Ulrika Johansson, Rolf Larsson, Bo Nilsson, Olle Korsgren et al.
    Tissue Engineering Part A
  62. The hypoxia-inducible factor 1/NOR-1 axis regulates the survival response of endothelial cells to hypoxia.
    Authors: Martorell L, Gentile M, Rius J, Rodriguez C, Crespo J, Badimon L, Martinez-Gonzalez J
    Mol. Cell. Biol., 2009-08-31;29(21):5828-42.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  63. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo.
    Authors: Rennel ES, Varey AH, Churchill AJ, Wheatley ER, Stewart L, Mather S, Bates DO, Harper SJ
    Br. J. Cancer, 2009-08-25;101(7):1183-93.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  64. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.
    Authors: Ponticelli S, Marasco D, Tarallo V, Albuquerque RJ, Mitola S, Takeda A, Stassen JM, Presta M, Ambati J, Ruvo M, De Falco S
    J. Biol. Chem., 2008-10-15;283(49):34250-9.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: ELISA Development
  65. Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.
    Authors: Fan F, Gray MJ, Dallas NA, Yang AD, Van Buren G, Camp ER, Ellis LM
    Mol. Cancer Ther., 2008-09-01;7(9):3064-70.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  66. A dual-tag microarray platform for high-performance nucleic acid and protein analyses
    Authors: Olle Ericsson, Jonas Jarvius, Edith Schallmeiner, Mathias Howell, Rachel Yuan Nong, Hendrik Reuter et al.
    Nucleic Acids Research
  67. Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways.
    Authors: Klettner A, Roider J
    Invest. Ophthalmol. Vis. Sci., 2008-04-25;49(10):4523-7.
    Species: Porcine
    Sample Types: Cell Lysates
    Applications: Western Blot
  68. Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b.
    Authors: Qiu Y, Bevan H, Weeraperuma S, Wratting D, Murphy D, Neal CR, Bates DO, Harper SJ
    FASEB J., 2007-11-21;22(4):1104-12.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: ELISA Development
  69. Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects.
    Authors: Yamagata M, Rook SL, Sassa Y, Ma RC, Geraldes P, Goddard L, Clermont A, Gao B, Salti H, Gundel R, White M, Feener EP, Aiello LP, King GL
    FASEB J., 2006-10-01;20(12):2058-67.
    Species: Bovine
    Sample Types: Cell Culture Supernates
    Applications: ELISA Development
  70. Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment.
    Authors: Lucerna M, Zernecke A, de Nooijer R, de Jager SC, Bot I, van der Lans C, Kholova I, Liehn EA, van Berkel TJ, Yla-Herttuala S, Weber C, Biessen EA
    Blood, 2006-09-21;109(1):122-9.
    Species: Human
    Sample Types: Whole Tissue
    Applications: ICC
  71. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
    Authors: Moreno MJ, Ball M, Andrade MF, McDermid A, Stanimirovic DB
    Glia, 2006-06-01;53(8):845-57.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  72. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term.
    Authors: Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, Hunter AJ, Soothill PW, Read M, Donaldson LF, Harper SJ
    Clin. Sci., 2006-05-01;110(5):575-85.
    Species: Human
    Sample Types: Tissue Homogenates
    Applications: ELISA Development
  73. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
    Authors: Lee A, Frischer J, Serur A, Huang J, Bae JO, Kornfield ZN, Eljuga L, Shawber CJ, Feirt N, Mansukhani M, Stempak D, Baruchel S, Bender JG, Kandel JJ, Yamashiro DJ
    Cancer Res., 2006-04-15;66(8):4378-84.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  74. Age-associated aortic stenosis in apolipoprotein E-deficient mice.
    Authors: Tanaka K, Sata M, Fukuda D, Suematsu Y, Motomura N, Takamoto S, Hirata Y, Nagai R
    J. Am. Coll. Cardiol., 2005-07-05;46(1):134-41.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  75. Suppression of vascular endothelial growth factor expression at the transcriptional and post-transcriptional levels
    Authors: Heung-Sun Kwon, Hyun-Chul Shin, Jin-Soo Kim
    Nucleic Acids Research
  76. Human peripheral blood eosinophils induce angiogenesis.
    Authors: Puxeddu I, Alian A, Piliponsky AM, Ribatti D, Panet A, Levi-Schaffer F
    Int. J. Biochem. Cell Biol., 2005-03-01;37(3):628-36.
    Species: Chicken
    Sample Types: Whole Tissue
  77. The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus.
    Authors: Djavani M, Topisirovic I, Zapata JC, Sadowska M, Yang Y, Rodas J, Lukashevich IS, Bogue CW, Pauza CD, Borden KL, Salvato MS
    J. Virol., 2005-02-01;79(4):2461-73.
    Species: Primate - Macaca mulatta (Rhesus Macaque)
    Sample Types: Whole Tissue
    Applications: IHC-P
  78. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
    Authors: Vijayan V, Shukla N, Johnson JL, Gadsdon P, Angelini GD, Smith FC, Baird R, Jeremy JY
    J. Vasc. Surg., 2004-11-01;40(5):1011-9.
    Species: Porcine
    Sample Types: Whole Tissue
    Applications: IHC-P
  79. Alterations in angiogenic growth factors and neuronal nitric oxide synthase expression in chronic cavernosal ischemia.
    Authors: Wang T, Soker S, Atala A, Siroky MB, Azadzoi KM
    Int. J. Impot. Res., 2004-10-01;16(5):403-11.
    Species: Rabbit
    Sample Types: Whole Tissue
    Applications: IHC
  80. Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation.
    Authors: Seo KH, Lee HS, Jung B, Ko HM, Choi JH, Park SJ, Choi IH, Lee HK, Im SY
    Cancer Res., 2004-09-15;64(18):6482-8.
    Species: Porcine
    Sample Types: Whole Cells
    Applications: Neutralization
  81. Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries.
    Authors: Wright JL, Tai H, Churg A
    Am. J. Respir. Cell Mol. Biol., 2004-07-08;31(5):501-9.
    Species: Guinea Pig
    Sample Types: Whole Tissue
    Applications: IHC-P
  82. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops.
    Authors: Masood R, Kundra A, Zhu S, Xia G, Scalia P, Smith DL, Gill PS
    Int. J. Cancer, 2003-05-01;104(5):603-10.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  83. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis.
    Authors: Giuliani N, Colla S, Lazzaretti M, Sala R, Roti G, Mancini C, Bonomini S, Lunghi P, Hojden M, Genestreti G, Svaldi M, Coser P, Fattori PP, Sammarelli G, Gazzola GC, Almici C, Caramatti C, Mangoni L, Rizzoli V
    Blood, 2003-03-20;102(2):638-45.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  84. Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome.
    Authors: Keane MP, Donnelly SC, Belperio JA, Goodman RB, Dy M, Burdick MD, Fishbein MC, Strieter RM
    J. Immunol., 2002-12-01;169(11):6515-21.
    Species: Human
    Sample Types: BALF, Whole Tissue
    Applications: ELISA Development, IHC-P
  85. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels.
    Authors: Argraves WS, Larue AC, Fleming PA, Drake CJ
    Dev. Dyn., 2002-11-01;225(3):298-304.
    Species: Avian - Quail, Mouse
    Sample Types: In Vivo, Whole Tissue
    Applications: IHC-Fr, Neutralization
  86. The neurotrophic effects of different human dental mesenchymal stem cells
    Authors: MK Kolar, VN Itte, PJ Kingham, LN Novikov, M Wiberg, P Kelk
    Sci Rep, 2017-10-03;7(1):12605.

FAQs

  1. Does Human VEGF165 Antibody, Catalog # AF-293-NA, recognize VEGF189?

    • Yes, AF-293-NA detects VEGF189

View all Antibody FAQs
Loading...

Reviews for Human VEGF165 Antibody

Average Rating: 4.5 (Based on 2 Reviews)

5 Star
50%
4 Star
50%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human VEGF165 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human VEGF165 Antibody
By Zoia Levashova on 06/22/2018
Application: Meso Scale Discovery Sample Tested: Aqueous humor,Retina/choroid,Vitreous humor Species: Porcine

After labeling with Sulfo-Tag, used as a detection reagent in MSD assay to detect ocular VEGF level in a swine model of laser-induced choroidal neovascularization. A standard curve with pig VEGF from Bio-Rad (Cat# PPP030) is shown (2-8,000 pg/ml).


Human VEGF165 Antibody
By Dong Liu on 11/23/2015
Application: B/N Sample Tested: Primary pumonary arterial endothelial cell lysate Species: Human

Neutralization of recombinant VEGF-induced VEGFR2 phosphorylation.